The QualityStocks Daily Friday, March 29th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (ALPE) +58.33%

StockMarketWatch (CSSE) +36.37%

StocksToBuyNow (RGNP) +34.62%

The QualityStocks Daily Stock List

Patriot Gold Corp. (PGOL)

Investopedia, The Street, Proactive Investors, Stockwatch, Barchart, Dividend Investor, YCharts, Wallet Investor, Real Pennies, OtcWizard, Standout Stocks, Marketwired, and Gold Investment Letter reported beforehand on Patriot Gold Corp. (PGOL), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Patriot Gold Corp. is a precious metals exploration and production company listed on the OTC Markets’ OTCQB. Its mission is to discover and develop significant gold and silver assets in Arizona and Nevada. Currently, the Company holds a portfolio of four projects. These are the Moss project in Arizona and three in Nevada (Bruner, Vernal, and Windy Peak). Patriot Gold is based in Las Vegas, Nevada.

The Company holds a 3 percent royalty in the Moss Mine in Arizona, an interest in the Bruner gold project in Nevada, and a 100 percent interest in the Windy Peak and Vernal projects in Nevada. The Moss Mine Project is within the historic Oatman District, 10 miles east of Bullhead City, Arizona and roughly 70 miles southeast of Las Vegas. Northern Vertex Mining Corp. is the owner of the Moss Mine. The Moss Mine entered commercial production as of the beginning of September 2018.

The Vernal gold project is in its early stage. This property is approximately 140 miles east-southeast of Reno, Nevada, on the west side of the Shoshone Mountains. This property comprises 12 unpatented mining claims (240 acres).

The Windy Peak Gold Project comprises 79 unpatented mineral claims in the Fairview mining district in southwest Nevada. Windy Peak is easily accessed. It is about 45 miles southeast of Fallon and 6 miles from Middlegate.

Patriot Gold owns a 2 percent royalty in the Bruner gold project. The Bruner gold project property is approximately 130 miles east-southeast of Reno, Nevada. It is at the northern end of the Paradise Range and 45 miles northwest of the Round Mountain Mine. Canamex Resources Corp. is the owner of the Bruner gold project.

The Bruner and Vernal gold projects are in Nevada's Walker Lane, which hosts many major deposits. These include the Goldfield (more than 5 million ounces of post production and current reserves) and the Comstock (more than 8 million ounces).

This month, Patriot Gold announced that it completed an initial phase of drilling exploration at the Windy Peak Project in Churchill County, Nevada, beginning in September 2018. At present, the Windy Peak deposit is interpreted as a low-sulfidation, epithermal gold deposit positioned marginal to and likely associated with a caldera ring fracture zone.

Intersections between ring fractures and regional normal faults in the Windy Peak Project area are especially favorable exploration targets. They offer the unique combination of fluid conduits and structural controls known to concentrate high-grade mineralization.

Patriot Gold Corp. (PGOL), closed Friday's trading session at $0.0728, even for the day, on 2,900 volume. The average volume for the last 3 months is 10,911 and the stock's 52-week low/high is $0.0438/$0.15.

chart

International Stem Cell Corp. (ISCO)

Tip.us, MissionIR, Serious Traders, Tiny Gems, BioCentury, Market Screener, Stock Invest, Marketbeat, Barchart, GuruFocus, Equity Clock, Research Gate, Canadian Insider, StocksToBuyNow, Zacks, Morningstar, and MarketWatch reported beforehand on International Stem Cell Corp. (ISCO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

International Stem Cell Corp. is a clinical stage biotechnology company listed on the OTC Markets’ OTCQX. It is developing stem cell-based therapies and biomedical products. The Company’s emphasis is on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. International Stem Cell has a research facility in Oceanside, California. The Company is based in Carlsbad, California.

International Stem Cell scientists have created the first parthenogenetic, homozygous stem cell line. The Company produces and markets specialized cells and growth media for therapeutic research globally via its subsidiary Lifeline Cell Technology and stem cell-based skin care products via its subsidiary Lifeline Skin Care.

International Stem Cell’s core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). The hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. They offer the potential to create the first true stem cell bank, UniStemCell™. The UniStemCell™ bank is the life science industry’s first collection of non-embryonic histocompatible human stem cells available for research and commercial use. The human leukocyte antigen (HLA) system represents antigens crucial for transplantation.

This past January, International Stem Cell announced that the United States Patent and Trademark Office (USPTO) granted the Company US Patent No. 10,172,890 on the topical use of lysate from human parthenogenetic (non-embryonic) stem cells to visibly improve signs of skin aging. The patented stem cell lysate is encapsulated and delivered from protective liposomes. It is combined with antioxidants, vitamins and peptides to provide skin benefits including decreasing the depth/number of facial fine lines and wrinkles, increasing skin elasticity/firmness, and improving skin hydration.

Last month, International Stem Cell announced that the results of its preclinical studies in traumatic brain injury (TBI) were published in Theranostics, a prestigious peer-reviewed medical journal. The publication, titled, “Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model,” demonstrated that the clinical-grade neural stem cells used in the Company’s Parkinson’s disease clinical trial, ISC-hpNSC®, considerably improve TBI-associated motor, neurological, and cognitive deficits without any safety issues. The paper is available on International Stem Cell’s website.

International Stem Cell Corp. (ISCO), closed Friday's trading session at $1.12, down 17.04%, on 26,477 volume with 24 trades. The average volume for the last 3 months is 6,008 and the stock's 52-week low/high is $1.03/$1.89.

chart

Diego Pellicer Worldwide, Inc. (DPWW)

Business Insider, The Street, Barchart, 4-Traders, MarketWatch, InvestorsHub, Insider Financial, StockAnalyst24, Stockhouse, GlobeNewswire, Daily Marijuana Observer, Penny Stock Tweets, Barchart, Stock Invest, Seeking Alpha, Financial Content, and PR Newswire reported earlier on Diego Pellicer Worldwide, Inc. (DPWW), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Diego Pellicer Worldwide, Inc. is a real estate and consumer retail development company. It concentrates on developing the Company as the world’s first "premium" marijuana brand. Its tenants are stand-alone, independent businesses and Diego Pellicer Worldwide has no ownership in them. OTCQB-listed, Diego Pellicer Worldwide has its corporate headquarters in Seattle, Washington.

The Company’s initial revenues originate from leasing real estate and selling non-cannabis related products. Diego Pellicer does not grow or sell marijuana or marijuana infused products. It leases legally compliant locations for growing, retailing, or the medical dispensing of marijuana. 

The Company is where responsible marijuana connoisseurs and sommeliers assemble to explore the world of premium marijuana. Diego Pellicer is the international leader in property acquisitions and leasing in the developing cannabis space. Its initial focus is to acquire and develop legally compliant real estate locations for the purposes of leasing them to State licensed companies in the cannabis industry.

Diego Pellicer participates in the profit of café operations of non-infused products; participates in the profit of ancillary products, including branded apparel; and in some instances, it signs contracts with its tenants, with the right to acquire at its discretion. The Company has secured numerous premier locations in Colorado, Washington, and Oregon. Its first flagship store tenant, Diego Pellicer-Washington (3,000 sq. ft. space) passed its final inspection for retail marijuana sales and began operations in Q4 2016. This flagship store features high-end cannabis products and accessories.

Last month, Diego Pellicer Worldwide announced that Diego Pellicer - Colorado celebrated its second anniversary on Valentine's Day announcing record-breaking sales. Diego Pellicer Worldwide announced the Denver licensee's location reported a 111 percent year-over-year growth from January 2017 to January 2019.

Mr. Ron Throgmartin, Chief Executive Officer of Diego Pellicer Worldwide, said, “We congratulate Diego Pellicer – Colorado's team on its success. With our leadership, branding model and experience, we look forward to helping other retailers and operators experience such prosperity."

Diego Pellicer Worldwide, Inc. (DPWW), closed Friday's trading session at $0.0452, down 9.60%, on 212,429 volume with 29 trades. The average volume for the last 3 months is 519,904 and the stock's 52-week low/high is $0.0116/$0.355.

chart

Energy Services of America Corp. (ESOA)

MicroCap Spotlight, Wallet Investor, GuruFocus, MarketWatch, Marketbeat, 4-Traders, Stockhouse, OTC Markets, TradingView, Real Pennies, Market Exclusive, Dividend Investor, Capital Cube, Streetwise Reports, and Barchart reported earlier on Energy Services of America Corp. (ESOA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Energy Services of America Corp. provides contracting services for energy related companies. The Company chiefly serves the gas, petroleum, power, chemical, and automotive industries. It also does some other incidental work including water and sewer projects. Energy Services of America is the parent company of C.J. Hughes Construction Company and Nitro Electric Company. Energy Services of America is based in Huntington, West Virginia and the Company lists on the OTCQB.

C.J. Hughes Construction Co, Inc. was established 70 years ago in West Virginia. C. J. Hughes Construction is one of the region’s foremost underground pipeline, utility, and facility construction contractors. C.J. Hughes provides an array of specialized services to the natural gas, petroleum, and water/wastewater industries.

Nitro Construction Services is a “full service” electrical contractor. Nitro provides high voltage, general power/control and instrumentation services. Since 2004, it has grown its Mechanical Services to include pipe fabrication, pipe erection, HVAC/R, as well as millwright services.

Energy Services of America builds, but does not own, natural gas pipelines for its customers. These pipelines are part of interstate and intrastate pipeline systems, which move natural gas from producing areas to consumption areas. Additionally, the Company builds and replaces gas line services to individual customers of the different utility companies. Most of its customers are in West Virginia, Virginia, Ohio, Pennsylvania, and Kentucky.

Concerning the gas industry, Energy Services of America primarily engages in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It engages in the construction of interstate and intrastate pipelines, with a focus on intrastate pipelines.

Energy Services of America provides a variety of services to the oil industry relating to pipeline, storage facilities, and plant work. For the power, chemical, and automotive industries, it provides a whole range of electrical and mechanical installations and repairs. These include substation and switchyard services, site preparation, equipment setting, pipe fabrication and installation, packaged buildings, transformers, and other ancillary work pertaining to these.

The Company’s other services include liquid pipeline construction, pump station construction, production facility construction, and water and sewer pipeline installations. Moreover, other services include different maintenance and repair services and other services related to pipeline construction.

Recently, Energy Services of America announced the filing of its quarterly report on Form 10-Q for the quarter ended December 31, 2018. The Company earned Revenues of $49.1 million for the three months ended December 31, 2018. Net Income available to Common Shareholders was $554,000 for the three months ended December 31, 2018. The Company had adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of $2.1 million ($0.15 per share) for the three months ended December 31, 2018. The backlog at December 31, 2018 was $59.3 million.

Energy Services of America Corp. (ESOA), closed Friday's trading session at $1.06, down 2.75%, on 1,795 volume with 3 trades. The average volume for the last 3 months is 9,252 and the stock's 52-week low/high is $0.60/$1.39.

chart

Gold Fields Limited (GFI)

Stock Twits, Mining Feeds, Stockhouse, 24hGold, Dividend Investor, Zacks, Street Insider, InvestorsHub, GuruFocus, last10k, MarketWatch, Junior Mining Network, The Street, Barchart, Stockwatch, StreetWise Reports, Proactive Investors, Morningstar, Equity Clock, Resource Clips, and StockChase reported earlier on Gold Fields Limited (GFI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Gold Fields Limited’s vision is to be the worldwide leader in sustainable gold mining. The Company produces gold and holds gold reserves and resources in South Africa, Ghana, Australia, and Peru. It has seven operating mines in these nations with attributable annual gold-equivalent production of about 2.2 million ounces. An internationally diversified producer of gold, Gold Fields is headquartered in Sandton, Johannesburg, South Africa. The Company lists on the OTC Markets.

Gold Fields has attributable gold Mineral Reserves of approximately 49 million ounces. The Company has gold Mineral Resources of approximately 104 million ounces. Attributable copper Mineral Reserves total 764 million pounds and Mineral Resources 4,881 million pounds.

Regarding its operations, Gold Fields has its Cerro Corona mine in Peru (Copper, Gold, Porphyry). In the West Africa region, it has its Tarkwa and Damang mines in Ghana (open pit gold mines). In the South Africa region, it has its South Deep mine. In the Australia region, Gold Fields’ assets comprise a 100 percent interest in the St Ives, Agnew, and Granny Smith mines in the Yilgarn region of Western Australia. They also include a 50 percent interest in the Gruyere project with Gold Road.

Gold Fields’ Tarkwa mine is the single largest gold producer in Ghana. It has annual production of greater than 500,000 ounces. The Tarkwa mine employs over 4,500 Ghanaians directly and by way of contractors, and close to 90 percent of its total procurement goes to Ghanaian vendors and suppliers.

Last month, Gold Fields announced normalized profit from continuing operations of US$27 million for the year ended December 2018 versus normalized profit of US$154 million for the year ended December 2017. A final dividend number 89 of 20 SA cents per share (gross) was payable on March 18, 2019. This gave a total dividend for the year ended December 2018 of 40 SA cents per share (gross).

Gold Fields Limited (GFI), closed Friday's trading session at $3.73, up 0.27%, on 3,056,351 volume with 8,456 trades. The average volume for the last 3 months is 5,292,342 and the stock's 52-week low/high is $2.40/$4.09.

chart

Integrity Applications, Inc. (IGAP)

Stockflare, Wallet Investor, MarketWatch, Simply Wall St, Stockopedia, PR Newswire, SmallCapVoice, Morningstar, Market Exclusive, Wallmine, Market Screener, OTC Markets Group, GuruFocus, Capital Cube, and YCharts reported previously on Integrity Applications, Inc. (IGAP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Integrity Applications, Inc. is the maker of GlucoTrack® - a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes. GlucoTrack® is a monitoring device that quickly measures and displays an individual's glucose level in about a minute without finger pricking or any pain. OTCQB-listed, Integrity Applications is headquartered in Wilmington, Delaware. The Company has a research and development (R&D) site in Ashdod, Israel.

Integrity Applications is focusing on three important initiatives - GlucoTrack Commercialization in Europe; GlucoTrack U.S. FDA (Food and Drug Administration) Approval; and a Product Roadmap. The Company’s initial principal emphasis is on the commercialization of GlucoTrack in Europe. GlucoTrack® has received CE Mark and KFDA approvals for type 2 diabetes and pre-diabetes. It is now in the early stages of commercialization in Europe, South Korea, as well as other geographies.

GlucoTrack® features a small sensor. This sensor clips to the earlobe and measures the user's glucose level using inventive and patented sensor technology. The measured signals undergo analysis using a proprietary algorithm and subsequently a calculated glucose level is displayed on a small handheld device the size of a small mobile phone.

The glucose results are stored in the device and used to project an estimated HbA1c level using a proprietary algorithm. The device can also display glucose values graphically. This allows the user to monitor glucose levels over time. GlucoTrack® is presently experimental in the United States. It is limited to investigational use only.

In December of 2018, Integrity Applications announced that it launched a Customer Experience Program in the Netherlands with its exclusive distributor MediReva and renowned clinical thought leaders in the field of diabetes care. The chief purpose of this program is to demonstrate real-world patient and health care professional experience with GlucoTrack® as a solution for daily glucose monitoring, and to further hasten commercialization and the reimbursement process in the Netherlands.

Integrity Applications, Inc. (IGAP), closed Friday's trading session at $0.25, down 7.41%, on 140 volume with 1 trade. The average volume for the last 3 months is 804 and the stock's 52-week low/high is $0.10/$2.15.

chart

Stem Holdings, Inc. (STMH)

Jet Life Penny Stocks, Wallet Investor, MarketWatch, Stockopedia, Barchart, 4-Traders, Stockhouse, GuruFocus, Simply Wall St, Dividend Investor, Investors Hangout, InvestorsHub, OTC Markets, last10k, Morningstar, Trading View, YCharts, Market Screener, and Midas Letter reported earlier on Stem Holdings, Inc. (STMH), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Stem Holdings, Inc. develops strategic brands for modern-day cannabis consumers. It builds and partners with companies in manifold sectors of the marijuana market from distribution to hemp cultivation. The Company purchases, improves, and leases properties for use in the cannabis production, distribution, and sales industry in the Oregon. OTCQB-listed, Stem Holdings is based in Boca Raton, Florida.

Stem Holdings’ brands and partnerships comprise Incredibles; Reefer Distribution Co.; Supernatural; Cannavore, and PUL. Moreover, the Company’s brands and partnerships include TJ’s Gardens; GreenTFarms; Travis x James; Dose-Ology; G Pen, and Craft Extracts.

Pertaining to the Company’s Cultivation & Processing Properties, it has its 42nd Street facility. This large warehouse serves as a premier indoor cultivation facility just outside of Eugene, Oregon. The property has 22 grow rooms.

Regarding Stem Retail Properties, the Company builds boutique retail stores. TJ’s Provisions is its flagship marijuana dispensary, located in Eugene, Oregon. Also, Stem has its TJ’s on Willamette marijuana dispensary about one mile from the University of Oregon campus. Additionally, the Company has its TJ's on Powell. This is a 2,000 square foot retail storefront in Portland, Oregon.

Stem also has its Mulino Farm greenhouse cultivation facility. This property in Clackamas County has 12 commercial-grade greenhouses. Stem also has its Applegate Farms cultivation facility that consists of 40 acres in Jacksonville, Oregon.

The Company also has its TJ’s Wallis. This Eugene property will include two facilities. They will provide space for cultivation and processing. This location has a first-rate commercial kitchen for edibles production and grow rooms and an extraction lab. The Company’s TJ’s Las Vegas property (5,450 square feet) outside of Vegas will allow cultivation, processing, and distribution operations for the fast-growing Nevada cannabis market.

Last week, Stem Holdings announced that its facility, TJ’s on Powell, received a license and final approval from the Oregon Liquor Control Commission to operate its newest dispensary location in Portland, Oregon. The new dispensary is located on Powell Boulevard. The Portland destination will feature an in-house coffee shop. It will serve hemp derived CBD coffee and tea to neighborhood patrons and daily commuters.

This week, Stem Holdings announced it executed a definitive agreement dated March 22, 2019 to acquire South African Ventures, Inc. (SAV). SAV has a joint venture (JV) with Profile Solutions, Inc. (PSIQ). The JV received preliminary approval to become the only licensed growing farm and processing plant for medical cannabis and industrial hemp in The Kingdom of eSwatini f/k/a Swaziland for a minimum of 10 years.

Mr. Adam Berk, Stem Holdings’ Chief Executive Officer, stated “We are very excited to expand our cannabis and industrial hemp operations globally through our partnership with The Kingdom of eSwatini. Products produced at the eSwatini Facility will initially be available for export to countries including but not limited to Australia and the European Union.” 

Stem Holdings, Inc. (STMH), closed Friday's trading session at $1.89, down 1.56%, on 2,816 volume with 11 trades. The average volume for the last 3 months is 12,076 and the stock's 52-week low/high is $1.319/$7.75.

chart

FieldPoint Petroleum Corp. (FPPP)

Stock Twits, Investing Note, InvestorsHub, Investors Hangout, Real Investment Advice, Market Screener, Wallet Investor, OTC Markets, Equity Clock, MarketWatch, The Street and Street Insider reported earlier on FieldPoint Petroleum Corp. (FPPP), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

FieldPoint Petroleum Corp. engages in the acquisition, development, and operation of oil and natural gas properties in the United States. The Company engages in oil and natural gas exploration, production, and acquisition, chiefly in Louisiana, New Mexico, Oklahoma, Texas, and Wyoming. OTCQB-listed, FieldPoint Petroleum is based in Austin, Texas.

The Company currently has varying ownership interests in 480 gross producing wells (96 net) in the aforementioned States. FieldPoint Petroleum’s strategy centers on expanding its reserve base. This is while boosting production and cash flow through the acquisition of leasehold interests and producing oil and gas wells.

FieldPoint Petroleum has more recently chosen to focus on promising areas for oil & gas exploration. These areas include the Lusk Field in Lea County, New Mexico, and FieldPoint’s Ranger Project in the Taylor Serbin Field near Giddings, Texas.

In projects like these, FieldPoint Petroleum partners with companies that complement internal expertise in evaluating opportunities and in making investment decisions. Pertaining to producing oil & gas properties, FieldPoint operates 19 wells. Independent contractors operate the other wells per standard industry contracts.

Regarding operated wells, the Company’s portfolio includes mainly low-touch, “pumper and electricity-only” wells in the Devonian, Ellenberger, and Morrow regions of West Texas and New Mexico. Higher maintenance fields are closer to home. These include the Taylor Serbin field near Giddings, Texas. The majority of FieldPoint’s production comes from its East Lusk and Serbin Fields.

In Wyoming, the Company is active in Converse County and Campbell County. FieldPoint Petroleum is active in Lea County, Chaves County, and Eddy County in New Mexico. In Texas, the Company is active in Andrews County, Midland County, and Lee & Bastrop Counties. In Louisiana, it is active in Caddo Parrish. In Oklahoma, FieldPoint is active in Grady County and Pontotoc County.

Recently, FieldPoint Petroleum announced financial results for Q2 ended June 30, 2018. Q2 2018 financial highlights versus the same period in 2017 include Revenues decreasing to $603,619  from $899,691. Net Income decreased to $179,263 from $1,747,186. Net Income per Share decreased, to basic $0.02 from $0.16 and fully diluted to $0.02 from $0.16.

Mr. Phillip Roberson, FieldPoint Petroleum President and Chief Financial Officer, said, "In the last year, we were able to pay down our credit line from approximately $6.5 million to a current balance of $2.6 million. A majority of these funds came from disposing of assets with zero value on our balance sheet, resulting in a net income of $179,263 in this quarter and $1,747,186 in the year ago quarter." 

FieldPoint Petroleum Corp. (FPPP), closed Friday's trading session at $0.09, up 32.35%, on 3,500 volume with 2 trades. The average volume for the last 3 months is 3,755 and the stock's 52-week low/high is $0.05/$0.243.

chart

Tofutti Brands, Inc. (TOFB)

Zacks, Stockrow, Stockwatch, The Stock Voice, Wallmine, The Street, Dividend Investor, Financial Content, Market Screener, Capital Cube, Marketbeat, Investors Hangout, Penny Stock Hub, YCharts, Stock Invest, Penny Stock Hub, Stockopedia, Infront Analytics, Market Exclusive, MarketWatch, and 4-Traders reported on Tofutti Brands, Inc. (TOFB), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Tofutti Brands, Inc. develops and distributes a complete line of dairy-free products. Its products are available throughout the U.S. and in greater than 30 countries. Tofutti Brands’ products serve the needs of millions of people who are allergic or intolerant to dairy, diabetic, kosher or vegan, and also those who desire to have a healthier low-fat diet. Tofutti Brands is based in Cranford, New Jersey.

All Tofutti Brands products are certified Kosher Parve. This means that none of its products ever contain any dairy whatsoever. This means no milk by-products either, including casein, whey, skim milk powder, or dairy lactic acid. The Company sells more than 40 milk-free foods. These include frozen desserts, cheese products and prepared frozen dishes. Tofutti Brands’ product line includes dairy-free ice cream pints, Tofutti Cutie® sandwiches, and Sour Supreme®, and Mintz's Blintzes®.

Regarding wholesale and/or food service, Premium Tofutti frozen dessert is available in 3-gallon containers. Tofutti Better Than Cream Cheese, Tofutti Better Than Ricotta Cheese, Tofutti Better Than Mozzarella Cheese, and Tofutti Better Than Sour Cream are available in a variety of bulk sizes. These include 30 lb. blocks, 5 lb. containers, and 1 oz. portion-controlled cups (cream cheese only).

Tofutti Brands also has an increasing assortment of prepared foods. These include Pizza Pizzaz® and the above-mentioned Mintz's Blintzes® - all made with Tofutti Brands’ milk-free cheeses, including Better Than Cream Cheese® and Sour Supreme®. Tofutti dairy free cheeses, frozen desserts, and frozen foods can be found in major supermarkets and health food stores.

Tofutti Brands, Inc. (TOFB), closed Friday's trading session at $1.80, up 13.92%, on 8,220 volume with 10 trades. The average volume for the last 3 months is 1,922 and the stock's 52-week low/high is $1.45/$3.17.

chart

BioCardia, Inc. (BCDA)

Penny Stock Hub, Investing Note, Penny Stock Tweets, Stockwatch, Stockopedia, Simply Wall St, Journal Transcript, Wallmine, TradingView, Insider Financial, 4-Traders, Marketbeat, and MarketWatch reported earlier on BioCardia, Inc. (BCDA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

BioCardia, Inc. is a leader in the development of complete solutions for cardiovascular regenerative therapies. Its biotherapeutic product candidates in clinical development are CardiAMP® (autologous minimally processed bone marrow cells [a patient’s own cells]) and CardiALLO® (allogenic culture expanded mesenchymal stem cells derived from bone marrow [donor-derived]) cell therapies. A clinical-stage regenerative medicine company, BioCardia has its corporate office in San Carlos, California.

The Company’s two therapeutic programs are enabled by its Helix™ transendocardial delivery systems and Morph® vascular access products, which are partnered to enable other promising biotherapeutic programs. Additionally, the Helix transendocardial delivery system is being used by several clinical partners in biotherapeutic clinical trials.

The Helix transendocardial delivery system is the foremost percutaneous catheter delivery system for cardiovascular regenerative medicine. Helix enables the local delivery of cell and gene-based therapies to treat heart failure, myocardial infarction, ischemia, and cardiac conduction disorders. BioCardia’s CardiALLO uses younger universal donor mesenchymal stem cells. The Company states that CardiALLO may be suitable for patients who are not optimal candidates for the CardiAMP therapy.

CardiAMP harnesses the potential of autologous minimally processed bone marrow cells, utilizing a companion diagnostic to identify patients most likely to benefit from the therapy. The design of the investigational CardiAMP cell therapy system is to deliver a high dose of a patient’s own bone marrow cells directly to the area of cardiac dysfunction to stimulate the body’s natural healing mechanism after a heart attack.

In September, BioCardia announced the issuance of two United States patents. U.S. Patent No. 10,035,982 relates to methods of preparing culture-expanded cells for the treatment of heart failure. This patent has broad claims on an approach for expanding mesenchymal stem cells in media derived from the blood of the same donor who has provided the source cells for culture expansion.

The second issued patent, U.S. Patent No. 10,071,226, describes a system for delivery of biotherapeutic agents to the heart. The patent claims a catheter system that may be used to attain heart access from the radial artery in a patient's wrist and subsequently advanced into a chamber of the heart to directly deliver biologic therapies.

Recently, BioCardia announced that positive data from two studies of its investigational CardiAMP stem cell therapy were presented on September 24, 2018 at the Transcatheter Cardiovascular Therapeutics (TCT) conference. Nine month results from the 10-patient roll-in cohort of the CardiAMP Heart Failure Trial (a Phase III pivotal trial) showed clinically meaningful improvements in symptoms, quality of life and exercise capacity, as measured by New York Heart Association class, Minnesota Living with Heart Failure Questionnaire and Six Minute Walk Distance, respectively.

BioCardia, Inc. (BCDA), closed Friday's trading session at $1.35, up 3.05%, on 908 volume with 2 trades. The average volume for the last 3 months is 3,372 and the stock's 52-week low/high is $0.89/$3.58.

chart

Fortem Resources, Inc. (FTMR)

Wolf Street, Stockwatch, OTC Markets, YCharts, InvestingOnline, Wallet Investor, Stockopedia, Marketbeat, Stockhouse, 4-Traders, Simply Wall St, InvestorsHub, Barchart, and Real Investment Advice reported on Fortem Resources, Inc. (FTMR), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Fortem Resources, Inc. is an oil and gas production, development, and exploration company. It has a diversified natural resource portfolio of mainly oil and gas assets and one gold asset. Fortem Resources has offices in Calgary, Alberta, and North Orem, Utah. Established in 2004, the Company formerly went by the name Strongbow Resources, Inc. It changed its name to Fortem Resources, Inc. in March 2017.

The Company’s properties are located in Western Canada, North America, and internatioanlly via five wholly-owned subsidiaries. These subsidiaries are Rolling Rock Resources, Black Dragon Energy, Colony Energy, Big Lake Energy, and City of Gold.

Fortem Resources announced in 2017 that it indirectly acquired by way of Rolling Rock Resources, LLC, a wholly-owned subsidiary, an undivided 75 percent interest in more oil and gas leases in the Mancos formation covering 2,313.09 acres. With an agreement entered into with Rockies Standard Oil Company, LLC, who holds the remaining 25 percent interest, the parties agreed to enter into a joint operating agreement covering the new leases. The leases are outside the AMI (Area of Mutual Interest) of its original joint venture (JV) lease holdings.

Regarding Fortem Resources’ Rolling Rock Resources subsidiary, Rolling Rock has the right to acquire a 50 percent working interest (WI) in and to certain leases, hydrocarbons, wells, agreements, equipment, surface rights agreements and assignable permits totaling around 101,888 acres (160 sections) at an 80 percent Net Revenue Interest (NRI) located in the Mancos formation in the Southern Uinta Basin, Utah.

Recently, Fortem Resources announced that it entered into an asset purchase agreement with a major Canadian oil and gas company to purchase a 100 percent WI in three Oil Leases encompassing a total of 20,719 hectares (51,200 acres) of heavy oil in north central Alberta. The rights to the Oil Leases, cover heavy oil of 12-16 API situated near the top of the Viking formation to the base of the Woodbend Group. The acquisition of the Oil Leases complements Fortem's existing land holdings of 12,800 acres directly adjacent to and to the south of the Oil Leases.

Fortem Resources, Inc. (FTMR), closed Friday's trading session at $1.98, up 7.03%, on 15,341 volume with 21 trades. The average volume for the last 3 months is 14,368 and the stock's 52-week low/high is $1.50/$3.95.

chart

alpha-En Corp. (ALPE)

Amigo Bulls, Penny Stock Hub, Stockscores, Speculating Stocks, Penny Stock Tweets, Street Insider, OTC Markets, Business Insider, Real Pennies, InvestorsHub, GuruFocus, Barchart, MarketWatch, and Wall Street Mover reported on alpha-En Corp. (ALPE), and we also report on the Company, here at the QualityStocks Daily Newsletter.

alpha-En Corp. is a clean technology business based in Yonkers, New York. The Company concentrates on enabling next generation battery technologies through developing and bringing to market high purity lithium metal and associated products produced in an environmentally sustainable way. alpha-En lists on the OTC Market Group’s OTCQB.

Alpha-En’s lithium metal is purer than what is presently available on the market. It is free of all base metals and common non-conductive impurities found in the existing commercial supply. The Company enables next generation energy storage. Its focus is on room temperature production of high purity lithium metal and associated products. Furthermore, alpha-En’s flexible disposition method can streamline battery manufacturing, leading to battery production cost benefits.

The room temperature process requires minimal electricity. In addition, utilizing Lithium Carbonate as feedstock reduces the Company’s raw material costs. The process is conducted at 20°-30°C. The room temperature, proprietary, patent pending process is mercury and chlorine free. This eliminates the use and release of toxic chemicals and expensive containment costs. Alpha-En’s proprietary technology and the absence of numerous chemicals usually required yields an extremely pure product - lithium metal without nonconductive impurities.

alpha-En and Cornell University have entered into a cooperative agreement to conduct sponsored research at the Baker Laboratory, under the direction of Mr. Héctor D. Abruña. Cornell University's agreement is for conducting vital analysis related to quantifying capacity and ion transport for the process of lithium thin film production patented by alpha-En.

The expectation is that the collaboration will take advantage of the hi-tech facilities available at Cornell University, especially the ability to study thin films of lithium "in operando", meaning – making movies, at the microscopic scale, of lithium film growth, as it happens in real time.

Argonne National Laboratory has entered into a collaborative agreement with alpha-En to assist in the scale and optimization of the Company’s process. alpha-En is sponsoring R&D (Research & Development) at Princeton University lead by Daniel Steingart, Ph.D. Professor of Mechanical and Aerospace Engineering and the Andlinger Center for Energy and the Environment at Princeton.

alpha-En Corp. (ALPE), closed Friday's trading session at $0.95, up 58.33%, on 7,653 volume with 7 trades. The average volume for the last 3 months is 1,959 and the stock's 52-week low/high is $0.519/$2.35.

chart

QPAGOS Corp. (QPAG)

Wallstreet Profiler, RedChip, Financial Content, Market Exclusive, ProfitableTrading, PennyDoctor, 4-Traders, Insider Tracking, Stockwatch, Marketwired, Insider Wisdom, Simply Wall St, Capital Cube, Dividend Investor, Investors Alley, Stockaholics, and Street Authority Daily reported earlier on QPAGOS Corp. (QPAG), and today we report on the Company, here at the QualityStocks Daily Newsletter.

QPAGOS Corp. is a provider of digital payment services for cash based and unbanked consumers in Mexico. The Company operates a network of self-service kiosks and applications designed to provide more convenient payment alternatives for consumers and more efficient billing for service providers. QPAGOS has its corporate headquarters in Mexico City, Mexico. The Company lists on the OTCQB.

QPAGOS has its state-of-the-art electronic payments technology. This technology provides users with a convenient and secure alternative for paying bills, products and services, using manifold devices. These include self-service kiosks, mobile, and Personal Computer (PC)-based applications.

For service providers, QPAGOS contributes to broaden their national collections footprint. This is while reducing transactional costs. For the Company’s distributors and franchisees, QPAGOS provides a very appealing income source as they can monetize high traffic physical spaces.

For advertisers, QPAGOS provides a new channel to attract business and interact with customers. QPAGOS self-service kiosks have an integrated second screen to broadcast advertising spots and messages. For QPAGOS users, there is no more waiting in line or trying to find a remote location to make frequent payments.

QPAGOS is working to capitalize on the unbanked alternative market. It is targeting the large Latin American market with a primary emphasis on Mexico. It is doing so through the steady rollout of its user-friendly bill payment kiosks and software.

QPAGOS announced in June of this year that it has partnered with Instituto del Deporte y la Recreación del Estado de Queretaro (INDEREQ), to deploy self-service kiosks and accept payments for INDEREQ members in the State of Queretaro, Mexico. INDEREQ was established as an independent public entity of the State of Queretaro. It has the mission of promoting and sponsoring sports in the State of Queretaro. Three of five initial QPAGOS self-service kiosks were installed at INDEREQ facilities.

Recently, QPAGOS announced that Q2 2018 results continued the strong revenue growth trend shown in Q1, as reported in the Company’s filed 10Q. Revenues for the three months ending June 30, 2018 were $1,701,763. This represents a 67.3 percent increase over the same quarter in 2017, and a 62.8 percent increase over the same January to June period of 2017. During Q2, collections at new locations, particularly municipalities, contributed to the growth, as QPAGOS government services solutions have expanded across the country.

QPAGOS Corp. (QPAG), closed Friday's trading session at $0.015, up 3.45%, on 192,500 volume with 9 trades. The average volume for the last 3 months is 586,575 and the stock's 52-week low/high is $0.0145/$0.60.

chart

NaturalShrimp, Inc. (SHMP)

OTC Dynamics, ThePennyPicks, SmallCapVoice, Born2Invest, Morningstar, Market Screener, Pennystockmania, PennyPickGains, WallstreetSurfers, Investors Hangout, The Street, and TradingView reported on NaturalShrimp, Inc. (SHMP), and we also report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, NaturalShrimp, Inc. is a global leader in aquaculture technology. The Company has developed and tested the first commercially-viable system for growing shrimp indoors. The system utilizes a proprietary technology to reliably produce healthy, naturally-grown shrimp weekly without the use of antibiotics or toxic chemicals. NaturalShrimp has developed a technology to produce fresh, gourmet-grade shrimp dependably and economically in an indoor, re-circulating, saltwater facility.

NaturalShrimp’s corporate office is in Dallas, Texas. Its production facility is outside of San Antonio, Texas. NaturalShrimp, Inc. owns 100 percent of NaturalShrimp Corporation, formed to operate in the U.S. and Canada, and 100 percent of NaturalShrimp Global, Inc., established to form International Joint Venture (JV) Partnerships.

NaturalShrimp operates a closed-system saltwater aquaculture facility. The facility produces high-grade Pacific White shrimp. It accomplishes this without using the antibiotics and chemical additives today’s shrimp farms require. The technology causes ammonia (NH3) to break down into risk-free nitrogen and hydrogen gas. Therefore, this eliminates one of the historically most demanding problems in shrimp aquaculture.

NaturalShrimp’s production facilities will be the aquaculture industry’s first truly eco-friendly, sustainable way of cultivating shrimp in high density environments.

The Company’s eco-friendly, bio-secure design does not depend on ocean water. It recreates the natural ocean environment allowing for high-density production that can undergo replication anywhere in the world.

The NaturalShrimp Automated Monitoring and Control system employs individual tank monitors to automatically control the feeding, the oxygenation, and the temperature of each of the facility tanks independently. Furthermore, a facility computer, running custom software, communicates with each of the controllers and performs more data acquisition functions that can report back to a supervisory computer from anywhere worldwide.

NaturalShrimp has installed an enhanced version of its patent pending, vibrio suppression technology system at the La Coste, Texas production facility. Recently, NaturalShrimp announced that its vibrio suppression technology system received extensive coverage from multiple Texas-based newspapers.

The design of the Company's vibrio suppression technology is to create higher sustainable shrimp population densities, consistent production, improved growth, higher survival rates, and top-quality food conversion in an all-natural ocean-type environment. Mr. Gerald Easterling, President, and one of NaturalShrimp's three Co-Founders, predicted, "What you see here will revolutionize indoor aquatic species and not just shrimp."

The original article stated, "That could have implications for a worldwide aquaculture industry estimated at more than $163 billion." The original article was written by Lynn Brezosky for the San Antonio Express-News. It was republished by permission in the Dallas, Ft. Worth and Waco newspapers.

NaturalShrimp, Inc. (SHMP), closed Friday's trading session at $0.210245, up 0.12%, on 3,943,620 volume with 487 trades. The average volume for the last 3 months is 14,968,761 and the stock's 52-week low/high is $0.005/$0.949.

chart

The QualityStocks Company Corner

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

Canadian cannabis cultivation firm The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) this morning announced that it will release its fourth quarter 2018 results after close of the financial markets on April 4, 2019. In addition, the company will host a conference call and webcast to review the results, with a question-and-answer session to follow. To view the full press release, visit http://nnw.fm/7Psqk.

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $6.34, up 0.32%, on 99,386 volume with 170 trades. The average volume for the last 3 months is 263,472 and the stock's 52-week low/high is $2.74/$8.42.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Global technology and value-added solutions group Net Element (NASDAQ: NETE), through its wholly owned subsidiary Aptito, delivers comprehensive business-management solutions and cloud-based point of sale (“POS”) for the restaurant industry. To view the full article, visit: http://nnw.fm/WTOt2.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $5.90, up 1.90%, on 82,458 volume with 416 trades. The average volume for the last 3 months is 66,401 and the stock's 52-week low/high is $3.75/$10.60.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. Medical cannabis has been available in Ohio for about three months now, but the latest data shows that the 20,000 people registered on the program haven’t displayed much eagerness to buy all the cannabis available at dispensaries. Here are some reasons that could explain this lack of buyer enthusiasm.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $4.31, up 5.38%, on 70,370 volume with 184 trades. The average volume for the last 3 months is 79,001 and the stock's 52-week low/high is $3.51/$7.97.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Small Caps Daily recently published a full report on Pressure BioSciences, Inc. (OTCQB: PBIO), after the Company's latest surge in press coverage piqued the publication's interest. The media interest is warranted, as it surrounds the commercial launch of Pressure BioSciences' Biopharmaceutical Contract Services Business. This newly launched vertical uses the Company's pressure-based technologies to provide a wide range of solutions across various industries, but the greatest impact will likely be in the field of life sciences.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.51, up 0.29%, on 2,600 volume with 11 trades. The average volume for the last 3 months is 15,226 and the stock's 52-week low/high is $1.52/$4.09.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a leading company in the cannabis industry that’s committed to providing premium brands and products, is seeking to grow the world’s best cannabis and become a leader in the global industry. As legalization spreads around the world, the cannabis industry continues to evolve from a market once limited to illicit recreational activity into one marked by innovative products utilized for myriad purposes, including medicinal, pharmaceutical, and health and wellness applications.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.65, up 1.16%, on 384,836 volume with 686 trades. The average volume for the last 3 months is 670,575 and the stock's 52-week low/high is $0.85/$2.04.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G), a Canadian-licensed producer (“LP”), is eyeing significant potential based on initial grow results at its Toronto production facility. To view the full article, visit: http://nnw.fm/aM9qD.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.65, up 21.36%, on 3,648,905 volume with 1,602 trades. The average volume for the last 3 months is 301,724 and the stock's 52-week low/high is $0.189/$1.875.

Recent News

chart

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) a royalty company for the U.S. licensed cannabis industry has provided comments on the announcement of The Secure and Fair Enforcement (SAFE) Banking Act (H.R. 1595), which was approved by the House Financial Services Committee on Thursday, March 28, 2019. The bill will advance to the House floor for deliberation by the full legislative assembly.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.1143, up 1.15%, on 5,755 volume with 6 trades. The average volume for the last 3 months is 38,704 and the stock's 52-week low/high is $0.0577/$0.5539.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade (OTCQB: SGMD) recently announced a planned acquisition of Sky Unlimited LLC, a major supplier to large commercial agricultural cultivation operations. To view the full article, visit: http://nnw.fm/8u1Xa.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.0546, up 7.06%, on 852,404 volume with 70 trades. The average volume for the last 3 months is 1,363,459 and the stock's 52-week low/high is $0.0425/$0.23.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

The U.S. market for cannabidiol-infused beverages is expanding rapidly, with forecasts calling for a valuation of $260 million by 2022. The revenue from such products could outpace all other industry representatives, capturing almost 20 percent of the edibles market by 2022, per industry data (http://nnw.fm/QPd6d). Addressing the market dynamics and seizing the new opportunities, companies like Youngevity International Inc. (NASDAQ: YGYI) are announcing innovative developments designed to provide health-conscious customers with more options. NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://nnw.fm/YGYI.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $5.70, off by 2.06%, on 102,338 volume with 559 trades. The average volume for the last 3 months is 217,136 and the stock's 52-week low/high is $0.0425/$0.23.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “Advanced Medical Technologies Provides Unprecedented Targeting in Cancer Therapy.” To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/XRt4d. To read the full editorial, visit: http://nnw.fm/tB7Li.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed the day's trading session at $1.555, off by 6.23%, on 41,173 volume with 200 trades. The average volume for the last 3 months is 48,172 and the stock's 52-week low/high is $0.949/$19.45.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

In back-to-back news releases, Nightfood Holdings Inc. (OTCQB: NGTF), the innovative company solving America’s $50 billion nighttime snacking problem, announced that it has secured retail distribution in North and South Carolina and has completed its second production run for all eight flavors of its Nightfood ice cream.

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.

Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.

With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.

Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.

Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.

Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.

Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed the day's trading session at $0.65, off by 2.23%, on 355,467 volume with 173 trades. The average volume for the last 3 months is 535,285 and the stock's 52-week low/high is $0.16/$0.92.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Full-scope, premium-cannabis company Green Hygienics Holdings (OTCQB: GRYN) is eying potential to expand its yield capabilities and overall market presence through a lucrative property acquisition. To view the full article, visit: http://nnw.fm/0IaU5.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.63, off by 4.26%, on 1,560 volume with 8 trades. The average volume for the last 3 months is 29,724 and the stock's 52-week low/high is $0.07/$0.722.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) announces the availability of a CannabisNewsAudio Publication titled, “CBD Going Mainstream amid Flood of New Products, Celebrity Endorsements and Emerging Consensus about Benefits.” To hear the CannabisNewsAudio version, visit: http://cnw.fm/aN7GS. To read the full editorial, visit: http://cnw.fm/FpDf2.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.52109, off by 0.57%, on 23,825 volume with 12 trades. The average volume for the last 3 months is 14,836 and the stock's 52-week low/high is $0.009/$1.139.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

ShieldSaver, a subsidiary of technology and investment company SinglePoint Inc. (OTCQB: SING), recently announced the launch of a new mobile app for the automotive glass space (http://nnw.fm/9Rr5l). Also today, the company was highlighted in an article looking at how technology is transforming the automotive industry. Currently, ShieldSaver is operational at Sacramento International Airport and Wally Park’s Denver International Airport. Some of the innovation feeds off ideas from other industries, such as the vehicle repair app created by SinglePoint Inc. (OTCQB: SING) (SING Profile).

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0166, off by 1.54%, on 1,626,984 volume with 93 trades. The average volume for the last 3 months is 5,793,730 and the stock's 52-week low/high is $0.0106/$0.068.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.